Home > News > The Entrepreneurial Bug
October 8th, 2009
The Entrepreneurial Bug
Abstract:
Cory Berkland's interest in business developed during his graduate engineering studies and blossomed into two companies, within which he still plays an active role. While Berkland was working on his Ph.D. in chemical and biological engineering at the University of Illinois, Urbana-Champaign, faculty members there started a company that incorporated Berkland's research on fabricating micro- and nanostructures from biodegradable polymers. That venture didn't succeed, but it "opened up my eyes to the possibility of starting a business," says Berkland, now an assistant professor of chemical and petroleum engineering at the University of Kansas, Lawrence.
In March 2007, 4 years after earning his Ph.D., Berkland and biotech veteran George Laurence started Savara Pharmaceuticals, now headquartered in Austin, Texas.
The company applies Berkland's work making nanoscale particles to pharmaceuticals. Some drugs are better administered as a dry-powder inhalant than as a water-soluble compound, but controlling the size of the dry-powder particles has been difficult. Savara's technology, based on Berkland's research, provides control over the particles' size and prevents them from clumping together, making delivery of the drug more effective.
Source:
sciencemag.org
Bookmark:
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Possible Futures
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
Nanobiotechnology
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||